SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-23-003308
Filing Date
2023-03-08
Accepted
2023-03-08 16:09:31
Documents
14
Period of Report
2023-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-8k_20230308.htm   iXBRL 8-K 43323
2 EX-99.1 tcon-ex991_24.htm EX-99.1 101552
3 GRAPHIC gjsuk12km3uy000001.jpg GRAPHIC 12142
  Complete submission text file 0001564590-23-003308.txt   303084

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tcon-20230308.xsd EX-101.SCH 5605
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20230308_lab.xml EX-101.LAB 19329
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20230308_pre.xml EX-101.PRE 11498
8 EXTRACTED XBRL INSTANCE DOCUMENT tcon-8k_20230308_htm.xml XML 3564
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 23716220
SIC: 2836 Biological Products, (No Diagnostic Substances)